NasdaqGS:ALMRLife Sciences
Alamar Biosciences (ALMR) Stock Price Jumps As Margin Gains Meet Loss Pressure
The market just rewrote the Alamar Biosciences story in one session. The stock surged 30.7% to US$36.57 after its first post‑IPO quarter as a listed company, even though the business is still running losses. That kind of jump puts expectations on a different level.
The headline from these earnings is simple. Revenue reached US$29.4m in Q2 and gross margin hit 60%, an all time high for the company, while Alamar reported a net loss of US$13.2m. For a high growth proteomics platform, this...